Solaris Pharma Corporation
14 drugs in NADAC|14 Generic,0 Brand
Solaris Pharma Corporation lists 14 NDCs in the CMS NADAC file (14 generic, 0 brand), at an average NADAC of $2.00 per unit, with a week-over-week move of +1.4% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
14
14G / 0B
Avg Price / Unit
$1.9961
$0.06 – $6.50
Avg 7d Change
+1.36%
Across 14 drugs with changes
7d Activity
of 14 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
DICYCLOMINE HYDROCHLORIDE market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Lincosamide Antibacterial therapeutic class
Review the broader class where Solaris Pharma Corporation has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does Solaris Pharma Corporation make?
Solaris Pharma Corporation lists 14 NDCs in the CMS NADAC file — 14 generic and 0 brand products.
What is the average price of Solaris Pharma Corporation drugs?
The average NADAC across Solaris Pharma Corporation's portfolio is $1.9961 per unit, ranging from $0.0590 to $6.5039.
What types of drugs does Solaris Pharma Corporation make?
Solaris Pharma Corporation makes drugs across 6 FDA pharmacologic classes. The most common by NDC count are Lincosamide Antibacterial (5), Retinoid (4), Anticholinergic (4), Estrogen (1), Aminoglycoside Antibacterial (1).
Has Solaris Pharma Corporation had any drug recalls?
No FDA enforcement recalls are matched to Solaris Pharma Corporation in the openFDA feed.
How has Solaris Pharma Corporation's pricing changed recently?
Over the past 7 days, 7 Solaris Pharma Corporation products rose and 7 fell, with a portfolio-wide average change of +1.4%.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
TAZAROTENE 0.1% GEL Tazarotene | $6.5039 per GM | -0.21% |
TAZAROTENE 0.05% GEL Tazarotene | $5.3138 per GM | +14.67% |
CLINDA-TRETINOIN 1.2%-0.025% clindamycin phosphate and tretinoin | $4.3119 per GM | -0.38% |
CLINDA-TRETINOIN 1.2%-0.025% clindamycin phosphate and tretinoin | $3.5063 per GM | +3.20% |
CLINDAMYCIN PHOSPHATE 1% GEL clindamycin phosphate | $3.4015 per ML | -2.28% |
ESTRADIOL 0.06% 1.25G GEL PUMP Estradiol | $3.3872 per GM | -0.80% |
NEOMYCIN 500 MG TABLET Neomycin Sulfate | $0.8331 per EA | -2.18% |
CLINDAMYCIN PH 1% GEL clindamycin phosphate | $0.1424 per GM | +2.12% |
METRONIDAZOLE VAGINAL 0.75% GL Metronidazole | $0.1406 per GM | -0.54% |
CLINDAMYCIN PH 1% GEL clindamycin phosphate | $0.1307 per GM | -0.95% |
DICYCLOMINE 10 MG CAPSULE DICYCLOMINE HYDROCHLORIDE | $0.0777 per EA | +2.60% |
DICYCLOMINE 10 MG CAPSULE DICYCLOMINE HYDROCHLORIDE | $0.0777 per EA | +2.60% |
DICYCLOMINE 20 MG TABLET DICYCLOMINE HYDROCHLORIDE | $0.0590 per EA | +0.56% |
DICYCLOMINE 20 MG TABLET DICYCLOMINE HYDROCHLORIDE | $0.0590 per EA | +0.56% |